Medical Properties Trust/$MPW

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Medical Properties Trust

Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.

Ticker

$MPW

Primary listing

NYSE

Employees

118

MPW Metrics

BasicAdvanced
$3.3B
-
-$2.39
1.32
$0.32
5.78%

What the Analysts think about MPW

Analyst ratings (Buy, Hold, Sell) for Medical Properties Trust stock.

Bulls say / Bears say

On June 17, 2025, MPT and its Praemia REIM joint venture refinanced €702.5 million in non-recourse debt at a fixed 5.1% rate, highlighting MPT’s capacity to obtain long-term, attractive financing for its healthcare assets. (SEC 10-Q)
MPT’s share of favorable fair value adjustments from its Utah partnership totaled $21 million for the six months ending June 30, 2025, reflecting strong market valuations for its hospital real estate portfolio. (SEC 10-Q)
In January 2025, MPT priced $1.5 billion of 8.500% USD senior secured notes and €1.0 billion of 7.000% Euro notes due 2032, refinancing maturing debt and supporting growth, which demonstrates strong investor demand for its secured issuances. (Medical Properties Trust IR)
MPT recorded $30 million of unfavorable non-cash fair value adjustments in Q1 2025, mainly tied to its investments in PHP Holdings and Aevis, pointing to valuation headwinds in its investment portfolio. (SEC 10-Q)
Normalized FFO dropped 43% year-over-year to $81.1 million in Q1 2025, due to lower revenues from asset disposals and higher interest expenses following recent refinancing, raising questions about the trust’s earnings strength. (SEC 10-Q)
MPT’s January 2025 issuance of senior secured notes at a blended rate of 7.885% highlights higher borrowing costs, which could impact future cash flows and leverage. (Medical Properties Trust IR)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.

MPW Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MPW Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MPW

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

FAQs